Director Share Dealings - Chemometec A/S (CHEMM)

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

≈ Figures for the value of trade may not add up due to rounding.

Recent deals

Date	Name and position (if held)	Deal type	Number of shares dealt	Price per share	Value of trade ≈	Shares remaining
26 March 2026	Hans Martin GlensbjergOther Chairman	Buy Regular purchase transaction	3,355	280.90 DKK	942,419.00 DKK	710,037
26 March 2026	Kim NicolajsenCFO	Buy Regular purchase transaction	550	275.80 DKK	151,690.00 DKK	1,500
25 March 2026	Hans Martin GlensbjergOther Chairman	Buy Regular purchase transaction	68,045	280.30 DKK	19,073,013.00 DKK	706,682
25 March 2026	Niels ThestrupChairman of the Board	Buy Regular purchase transaction	1,100	271.60 DKK	298,760.00 DKK	4,334
27 February 2026	Betina HagerupIndependent Director	Buy Regular purchase transaction	483	413.00 DKK	199,479.00 DKK	776
5 February 2026	Niels ThestrupChairman of the Board	Buy Regular purchase transaction	420	475.00 DKK	199,500.00 DKK	3,234

End of results. Director deals are only available for the last 12 months.

5 most significant deals

Date	Name and position (if held)	Deal type	Number of shares dealt	Price per share	Value of trade ≈	Shares remaining
25 March 2026	Hans Martin GlensbjergOther Chairman	Buy Regular purchase transaction	68,045	280.30 DKK	19,073,013.00 DKK	706,682
26 March 2026	Hans Martin GlensbjergOther Chairman	Buy Regular purchase transaction	3,355	280.90 DKK	942,419.00 DKK	710,037
25 March 2026	Niels ThestrupChairman of the Board	Buy Regular purchase transaction	1,100	271.60 DKK	298,760.00 DKK	4,334
5 February 2026	Niels ThestrupChairman of the Board	Buy Regular purchase transaction	420	475.00 DKK	199,500.00 DKK	3,234
27 February 2026	Betina HagerupIndependent Director	Buy Regular purchase transaction	483	413.00 DKK	199,479.00 DKK	776

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.